Sign in →

Test ID LUCHM LiquidHALLMARK ctDNA and ctRNA


Shipping Instructions


Specimen must be received at Mayo Clinic Laboratories within 4 days of collection.



Necessary Information


1. Ask at order entry questions are required for testing to proceed.

If not ordering electronically, submit the following information with the specimen:

Original Diagnosis Date

Diagnosis: Lung, Breast, Colon, Prostate, Ovarian, Other, Not Specified

Subtype If Applicable

Disease Stage: Advanced Cancer, Other, Not Specified

Current Therapy and Response

Disease Status: Metastatic, Refractory, Progression, Recurrent, Relapse, Other, Not Specified

ICD-10 Codes

2. A pathology report is recommended. Testing may proceed without this information; however, it aids in providing a more thorough and accurate interpretation of results. Ordering healthcare professionals are strongly encouraged to provide the information and send with the specimen.



Specimen Required


Specimen Type: Whole blood

Supplies: Streck Tan Top Tube Kit (T715)

Container/Tube: Two 10-mL Streck cell-free DNA (cfDNA) blood collection tubes

Specimen Volume: 20 mL; 10 mL in two Streck tubes

Collection Instructions:

1. Invert several times to mix blood.

2. Send whole blood specimen in original tube. Do not centrifuge or aliquot.


Useful For

As an alternative to invasive tissue biopsies to assist in tumor profiling for diagnosis, predicting prognosis, and identifying targeted therapies for the treatment and management of patients with a solid tumor

 

This test is not useful for prenatal screening.

Method Name

Amplicon-Based Next-Generation Sequencing

Reporting Name

LiquidHALLMARK ctDNA and ctRNA

Specimen Type

WB Streck

Specimen Minimum Volume

See Specimen Required

Specimen Stability Information

Specimen Type Temperature Time Special Container
WB Streck Ambient 4 days Streck Black/Tan top

Reference Values

An interpretive report will be provided

Day(s) Performed

Monday through Friday

Report Available

8 to 12 days

Performing Laboratory

Lucence Health, Inc.

Test Classification

This clinical test was developed and its performance characteristics determined by Lucence Health Inc. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA does not require this test to go through premarket FDA review. This test is used for clinical purposes and should not be regarded as investigational or for research, unless otherwise stated in the report. Lucence Health Inc. is a Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory (CLIA ID Number: 05D2200843) and is accredited to College of American Pathologists (CAP) laboratory quality standards.

CPT Code Information

81479

LOINC Code Information

Test ID Test Order Name Order LOINC Value
LUCHM LiquidHALLMARK ctDNA and ctRNA Not Provided

 

Result ID Test Result Name Result LOINC Value
LU001 LiquidHALLMARK ctDNA and ctRNA Not Provided